330-452-9911 (Aultman Main)

Schedule an Appointment

*Please fill in all the required fields.

Do you have an order from a physician and want to schedule an appointment?

YES

NO

In order to assure you are getting the test your physician requires, it is important that you have the order. Please contact your physician to obtain an order so you can be scheduled properly.

 

Aultman Wait Times

Choose Immediate Care for colds/flu, sprains/strains and other minor injury/illness.


Go to the ER for major concerns and trauma. Call 911 for chest pain and stroke symptoms.

Menu

Medical Services

Support Services

Location Finder

Here's your guide to finding any of the facilities in the Aultman family of health services, including maps and contacts. 

Need a Doctor?

Aultman Medical Group's network of more than 240 providers is committed to high-level patient care.

Schedule an Appointment

Call 330-363-6288 or click below to complete an online form. 

 

Donate Today

You can help support and enhance services, and in turn, help patients and their families who benefit from care received at Aultman.

Breast Cancer

Below are the most current breast cancer trials Aultman has to offer. To learn more about a specific trial, please click the trial number below the trial sponsor in the table below.

Trial Sponsor

Study Type

         Condition

Intervention Type

National Cancer Institute
BR003

Treatment
Phase 3

Stage IB, IIA, IIB, IIIA, IIIC Triple- Negative Breast Cancer

Doxorubicin & cyclophosphamide +/- carboplatin

National Cancer Institute
B-51

Treatment
Phase 3

Stage IB or II Breast
Cancer

Standard vs. comprehensive radiation therapy

National Cancer Institute
A011401

Treatment
Phase 3

Role of Weight Loss in Early Breast Cancer

Health Education Program

National Cancer Institute
A011502
(ABC STUDY)

Treatment
Phase 3

HER2 Negative, Node Positive Breast Cancer

Aspirin vs. Placebo

National Cancer Institute
B-59

Treatment
Phase 3

Triple Negative Breast Cancer

Atezolizumab vs. Placebo

National Cancer Institute
S1501

Treatment
Phase 3

Metastatic HER 2+ Breast Cancer

Carvedilol vs. Placebo

National Cancer Institute
EA1151
(TMIST)

Screening
Phase 3

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Tomosynthesis Mammography

National Cancer Institute
MA.39
(TAILOR RT)

Treatment
Phase 3

Low Risk Node Positive Breast Cancer

Regional vs. Whole Breast Radiation or No Radiation

National Cancer Institute
A211601

Treatment
Phase 3

 

Companion Study to A011502
Aspirin vs. Placebo

National Cancer Institute
FB-12
(FACT 1)

Treatment
Phase 2 - Open Label

Early Stage HER2 Negative Breast Cancer

An Open-Label Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel Plus Trastuzumab and Pertuzumab in Early Stage Her2-Negative Breast Cancer Patients Selected with a Test Measuring Live Cell HER2 Signaling Transduction (FACT 1) 

National Cancer Institute
S1418

Treatment
Phase 3

Triple Negative Breast Cancer

 

Aultman Medical Group
"B-Treuh"

Treatment
Phase 2

Metastatic Breast Cancer, Hypothyroidism

 

EirGenix, Inc.
EGC002

Treatment
Phase 3

Early Stage HER2 Positive Breast Cancer

 

Location Finder

Here's your guide to finding any of the facilities in the Aultman family of health services, including maps and contacts. 

Need a Doctor?

Aultman Medical Group's network of more than 240 providers is committed to high-level patient care.

Schedule an Appointment

Call 330-363-6288 or click below to complete an online form. 

 

Donate Today

You can help support and enhance services, and in turn, help patients and their families who benefit from care received at Aultman.

What's Happening